C
Christoph Reissfelder
Researcher at Heidelberg University
Publications - 185
Citations - 5604
Christoph Reissfelder is an academic researcher from Heidelberg University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 29, co-authored 112 publications receiving 4233 citations. Previous affiliations of Christoph Reissfelder include German Cancer Research Center & University Hospital Heidelberg.
Papers
More filters
Journal ArticleDOI
Adjuvant therapy after resection of colorectal liver metastases: the predictive value of the MSKCC clinical risk score in the era of modern chemotherapy.
Nuh N. Rahbari,Nuh N. Rahbari,Christoph Reissfelder,Christoph Reissfelder,Henning Schulze-Bergkamen,Dirk Jäger,Markus W. Büchler,Jürgen Weitz,Jürgen Weitz,Moritz Koch,Moritz Koch +10 more
TL;DR: The Memorial Sloan-Kettering Cancer Center clinical risk score (MSKCC-CRS) offers a tool to select patients for adjuvant therapy after resection of CRC liver metastases and was associated with improved survival in the entire cohort.
The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III tri
Salah-Eddin Al-Batran,Thorsten Oliver Goetze,Daniel Wilhelm Mueller,Arndt Vogel,Michael Winkler,Sylvie Lorenzen,Alexander Novotny,Claudia Pauligk,Nils Homann,Thomas Jungbluth,Christoph Reissfelder,Karel Caca,Steffen Retter,Eva Horndasch,Julia Gumpp,Claus Bolling,Karl-Hermann Fuchs,Wolfgang Blau,Winfried Padberg,Michael Pohl,A. Wunsch,Patrick Michl,Frank Mannes,Matthias Schwarzbach,Harald Schmalenberg,Michael Hohaus,Christian Scholz,Christoph Benckert,Jorge Riera Knorrenschild,Veit Kanngießer,Thomas Zander,Hakan Alakus,Ralf-Dieter Hofheinz,C. Roedel,Manish A. Shah,Mitsuru Sasako,Dietmar Lorenz,Jakob R. Izbicki,Wolf O. Bechstein,Hauke Lang,Stefan Paul Moenig +40 more
TL;DR: If the RENAISSANCE concept proves to be effective, this could potentially lead to a new standard of therapy and patients with gastric or GEJ cancer and metastases will no longer be considered candidates for surgical intervention.
Journal ArticleDOI
Correlation of Circulating Angiogenic Factors with Circulating Tumor Cells and Disease Recurrence in Patients Undergoing Curative Resection for Colorectal Liver Metastases
Nuh N. Rahbari,Christoph Reissfelder,Monika Mühlbayer,Kathrin Weidmann,Christoph Kahlert,Markus W. Büchler,Jürgen Weitz,Moritz Koch +7 more
TL;DR: The notion that CAF may identify patients who benefit from adjuvant therapy or antiangiogenic agents warrants further investigation.
Journal ArticleDOI
Core needle biopsy versus incisional biopsy for differentiation of soft-tissue sarcomas: A systematic review and meta-analysis.
Emrullah Birgin,Cui Yang,Svetlana Hetjens,Christoph Reissfelder,Peter Hohenberger,Nuh N. Rahbari +5 more
TL;DR: This systematic review and meta‐analysis was to compare the diagnostic accuracy of core needle biopsy versus incisional biopsy in STS with reference to the final histopathological result.
Journal ArticleDOI
Impact of Intraoperative Re-resection to Achieve R0 Status on Survival in Patients With Pancreatic Cancer: A Single-center Experience With 483 Patients.
Philipp Nitschke,Andreas Volk,Thilo Welsch,Jonas Hackl,Christoph Reissfelder,Mohammad Rahbari,Marius Distler,Hans-Detlev Saeger,Jürgen Weitz,Nuh N. Rahbari +9 more
TL;DR: FS analysis with intraoperative re-resection should be performed routinely in patients undergoing pancreatic cancer surgery with the aim to achieve a R0 resection, according to the hypothesis that intraoperative frozen section (FS) and re-Resection results to achieve R0 status are associated with different long-term outcomes in pancreaticcancer patients.